Search Results - Tim West

Diagnostic Performance of Plasma Biomarkers for A/T/N Image Classification in Alzheimer's disease by Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Jeong‐Ha Lee, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Joel B. Braunstein, Daniel Connell, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho

Get full text

Predicting PET‐Based Amyloid and Tau Pathology Stages With Plasma Biomarkers in Alzheimer's disease by Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Jeong‐Ha Lee, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Joel B. Braunstein, Daniel Connell, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho

Get full text

Evaluation of the prospective use of blood biomarkers for Alzheimer’s disease in primary and secondary care by Sebastian Palmqvist, Gemma Salvadó, Niklas Mattsson‐Carlgren, Tim West, Ruben Smith, Rik Ossenkoppele, Suzanne E. Schindler, Kaj Blennow, Mark Monane, Philip B. Verghese, Joel B. Braunstein, Shorena Janelidze, Erik Stomrud, Pontus Tideman, Oskar Hansson

Get full text

APOE Genotype Modulates the Relationship Between Plasma p ‐tau217 and Amyloid Burden in Alzheimer's Disease by Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Mina Park, You Jin Kim, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Daniel Connell, Joel B. Braunstein, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho

Get full text

Differential Performance of p ‐tau217 in Reflecting Amyloid and Tau Stages in Cognitively Unimpaired and Impaired Individuals by Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Mina Park, You Jin Kim, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Daniel Connell, Joel B. Braunstein, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho

Get full text

Cerebrospinal fluid MTBR243 tau correlates with [18F] GTP1 Tau PET and the two biomarkers show similar correlations with clinical measures by Philip B. Verghese, Matthew R. Meyer, Shin‐Cheng Tzeng, Christina Rabe, Julie Lee, Anne Biever, Emilia Calderon, Edmond Teng, Cecilia Monteiro, Felix L Yeh, Kaleb Patania, Venky Venkatesh, Tim West, Tobias Bittner, Joel B. Braunstein

Get full text

Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia by Karly A. Cody, Lianlian Du, Rachel L. Studer, Erin M. Jonaitis, Sanjay Asthana, Bradley T. Christian, Nathaniel A. Chin, Kris M. Kirmess, Matthew R. Meyer, Kevin E. Yarasheski, Tim West, Philip B. Verghese, Joel B. Braunstein, Tobey J. Betthauser, Rebecca E. Langhough, Sterling C. Johnson

Get full text

Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial by Doris Patricia Molina‐Henry, Rema Raman, Andy Liu, Oliver Langford, Keith Johnson, Leona K. Shum, Crystal M. Glover, Shobha Dhadda, Michael Irizarry, Gustavo Jimenez‐Maggiora, Joel B. Braunstein, Kevin Yarasheski, Venky Venkatesh, Tim West, Philip B. Verghese, Robert A. Rissman, Paul Aisen, Joshua D. Grill, Reisa A. Sperling

Get full text

Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET by Petrice M. Cogswell, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Michael E. Griswold, Joel B. Braunstein, Tim West, Philip B. Verghese, Jonathan Graff‐Radford, Alicia Algeciras‐Schimnich, Val J. Lowe, Christopher G. Schwarz, Matthew L. Senjem, Jeffrey L. Gunter, David S. Knopman, Prashanthi Vemuri, Ronald C. Petersen, Clifford R. Jack

Get full text

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid by Matthew R. Meyer, Kristopher M. Kirmess, Stephanie Eastwood, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch, Venky Venkatesh, Ilana Fogelman, Mark Monane, Lucy Hanna, Gil D. Rabinovici, Barry A. Siegel, Rachel A. Whitmer, Charles Apgar, Randall J. Bateman, David M. Holtzman, Michael Irizarry, David Verbel, Pallavi Sachdev, Satoshi Ito, John Contois, Kevin E. Yarasheski, Joel B. Braunstein, Philip B. Verghese, Tim West

Get full text